Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
XLRNShowing 0 of 13 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in ACCELERON PHARMA INC
As of its Q3 2021 13F, Farallon Capital Management held 2,164,663 shares of XLRN (Acceleron Pharma), worth $372.5M. Farallon Capital Management's 13F filings listed XLRN from Q4 2018 to Q3 2021, 12 quarterly filings. XLRN was 1.7% of Farallon Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of XLRN: PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Avoro Capital Advisors LLC